
Katarina Sjögreen Gleisner
Professor
Publikationer
Visar av publikationer. Sorterade efter år och sen titel.
Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification
Johan Gustafsson, Erik Larsson, Michael Ljungberg, Katarina Sjögreen Gleisner
(2024) EJNMMI Physics, 11
Artikel i tidskriftAccuracy of patient-specific I-131 dosimetry using hybrid whole-body planar-SPECT/CT I-123 and I-131 imaging
Michaella Morphis, Johan A. van Staden, Hanlie du Raan, Michael Ljungberg, Katarina Sjögreen Gleisner
(2024) EJNMMI Physics, 11
Artikel i tidskrift3D printed non-uniform anthropomorphic phantoms for quantitative SPECT
Lovisa Jessen, Johan Gustafsson, Michael Ljungberg, Selma Curkic-Kapidzic, Muris Imsirovic, et al.
(2024) EJNMMI Physics, 11
Artikel i tidskriftFeasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera
Daniel Roth, Erik Larsson, Joanna Strand, Michael Ljungberg, Katarina Sjögreen Gleisner
(2024) EJNMMI Physics, 11
Artikel i tidskriftRetrospective evaluation of the predictive value of tumour burden at baseline [ 68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
Anni Gålne, Anna Sundlöv, Olof Enqvist, Katarina Sjögreen Gleisner, Erik Larsson, et al.
(2024) EJNMMI reports, 8 p.1-19
Artikel i tidskriftPhysics for molecular radiotherapy – The battle between science and simplicity
Glenn Flux, Katarina Sjögreen Gleisner, Manuel Bardies
(2024) Physica Medica, 124
Artikel i tidskriftRelationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
Carl Fredrik Warfvinge, Johan Gustafsson, Daniel Roth, Jan Tennvall, Johanna Svensson, et al.
(2024) Journal of Nuclear Medicine, 65 p.1070-1075
Artikel i tidskriftKidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs
Selma Curkic Kapidzic, Johan Gustafsson, Erik Larsson, Lovisa Jessen, Katarina Sjögreen Gleisner
(2024) Physica Medica, 120
Artikel i tidskriftA PBPK model for PRRT with [177Lu]Lu-DOTA-TATE : Comparison of model implementations in SAAM II and MATLAB/SimBiology
Valentina Vasić, Johan Gustafsson, Elham Yousefzadeh Nowshahr, Anna Stenvall, Ambros J. Beer, et al.
(2024) Physica Medica, 119
Artikel i tidskriftThe contest between internal and external-beam dosimetry : The Zeno's paradox of Achilles and the tortoise
Francesco Cicone, Katarina Sjögreen Gleisner, Anna Sarnelli, Luca Indovina, Jonathan Gear, et al.
(2024) Physica Medica, 117
Artikel i tidskriftImplementation of dosimetry for molecular radiotherapy; results from a European survey
Steffie Peters, Johannes Tran-Gia, Sam Agius, Oleksandra V. Ivashchenko, Jean Noël Badel, et al.
(2024) Physica Medica, 117
Artikel i tidskriftOn the use of solid 133Ba sources as surrogate for liquid 131I in SPECT/CT calibration : a European multi-centre evaluation
Johannes Tran-Gia, Ana M. Denis-Bacelar, Kelley M. Ferreira, Andrew P. Robinson, Christophe Bobin, et al.
(2023) EJNMMI Physics, 10
Artikel i tidskriftTraceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and Sweden
Cecilia Hindorf, Lovisa Jessen, Selma Curkic Kapidzic, Johan Blakkisrud, Johanna Dalmo, et al.
(2023) Physica Medica, 116
Artikel i tidskriftResults from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
Pablo Mínguez Gabiña, Katarina Sjögreen Gleisner, Marta Cremonesi, Caroline Stokke, Glenn Flux, et al.
(2023) European Journal of Nuclear Medicine and Molecular Imaging, 50 p.2595-2604
Artikel i tidskriftEFOMP policy statement NO. 19 : Dosimetry in nuclear medicine therapy – Molecular radiotherapy
Katarina Sjögreen-Gleisner, Glenn Flux, Klaus Bacher, Carlo Chiesa, Robin de Nijs, et al.
(2023) Physica Medica, 116
Artikel i tidskriftAveraging of absorbed doses : How matter matters
Johan Gustafsson, Michael Ljungberg, Gudrun Alm Carlsson, Erik Larsson, Carl Fredrik Warfvinge, et al.
(2023) Medical Physics, 50 p.6600-6613
Artikel i tidskriftMonte Carlo modelling of a compact CZT-based gamma camera with application to 177Lu imaging
Daniel Roth, Erik Larsson, Michael Ljungberg, Katarina Sjögreen Gleisner
(2022) EJNMMI Physics, 9
Artikel i tidskriftEANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Katarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, Francesco Cicone, Silvano Gnesin, et al.
(2022) European Journal of Nuclear Medicine and Molecular Imaging, 49 p.1778-1809
Artikel i tidskriftActivity Quantification from Planar Images
Katarina Sjögreen Gleisner
(2022) Series in Medical Physics and Biomedical Engineering, 1
Del av eller Kapitel i bokProperties of the Digital Image
Katarina Sjögreen Gleisner
(2022) Series in Medical Physics and Biomedical Engineering, 1
Del av eller Kapitel i bokDosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, et al.
(2022) Journal of Nuclear Medicine, 63 p.399-405
Artikel i tidskriftRelationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
Anna Stenvall, Johan Gustafsson, Erik Larsson, Daniel Roth, Anna Sundlöv, et al.
(2022) EJNMMI Research, 12
Artikel i tidskriftPhase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, Michael Ljungberg, Carl Fredrik Warfvinge, et al.
(2022) European Journal of Nuclear Medicine and Molecular Imaging, 49 p.3830-3840
Artikel i tidskriftEANM dosimetry committee series on standard operational procedures : a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
Carlo Chiesa, Katarina Sjogreen-Gleisner, Stephan Walrand, Lidia Strigari, Glenn Flux, et al.
(2021) EJNMMI Physics, 8
Artikel i tidskriftPeptide Receptor Radionuclide Therapy – Prospects for Personalised Treatment
A. Sundlöv, K. Sjögreen-Gleisner
(2021) Clinical Oncology, 33 p.92-97
Artikel i tidskriftA multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project
Johannes Tran-Gia, Ana M. Denis-Bacelar, Kelley M. Ferreira, Andrew P. Robinson, Nicholas Calvert, et al.
(2021) EJNMMI Physics, 8
Artikel i tidskriftPituitary function after high-dose 177Lu-DOTATATE therapy and long-term follow-up
Anna Sundlöv, Katarina Sjögreen-Gleisner, Jan Tennvall, Ludvig Dahl, Johanna Svensson, et al.
(2021) Neuroendocrinology , p.344-353
Artikel i tidskriftCharacterisation of a hand-held CZT-based gamma camera for 177Lu imaging
Daniel Roth, Erik Larsson, Anna Sundlöv, Katarina Sjögreen Gleisner
(2020) EJNMMI Physics, 7
Artikel i tidskriftBone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
Linn Hagmarker, Johanna Svensson, Tobias Ryden, Martijn van Essen, Anna Sundlöv, et al.
(2019) Journal of Nuclear Medicine, 60 p.1406-1413
Artikel i tidskriftAnalysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively
Pablo Mínguez, Emilia Rodeño, José Genollá, Maite Domínguez, Amaia Expósito, et al.
(2019) Physica Medica, 65 p.143-149
Artikel i tidskriftRe : Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
Stephan Walrand, Carlo Chiesa, Pablo Minguez Gabina, Nicolas Chouin, Jonathan Gear, et al.
(2019) Journal of Vascular and Interventional Radiology, 30 p.2047-2048
Artikel i tidskriftFeasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
Anna Sundlöv, Johan Gustafsson, Gustav Brolin, Nadja Mortensen, Rebecca Hermann, et al.
(2018) EJNMMI Physics, 5
Artikel i tidskriftEANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
Jonathan I. Gear, Maurice G. Cox, Johan Gustafsson, Katarina Sjögreen Gleisner, Iain Murray, et al.
(2018) European Journal of Nuclear Medicine and Molecular Imaging, 45 p.2456-2474
Artikel i tidskrift3-D Image-Based Dosimetry in Radionuclide Therapy
M. Ljungberg, K. Sjögreen Gleisner
(2018) IEEE Transactions on Radiation and Plasma Medical Sciences, 2 p.527-540
Artikel i tidskriftA method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation
Daniel Roth, Johan Gustafsson, Anna Sundlöv, Katarina Sjögreen Gleisner
(2018) Medical Physics, 45 p.5004-5018
Artikel i tidskriftInter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
Jill Wevrett, Andrew Fenwick, James Scuffham, Lena Johansson, Jonathan Gear, et al.
(2018) EJNMMI Physics, 5
Artikel i tidskriftFrom fixed activities to personalized treatments in radionuclide therapy : lost in translation?
G. D. Flux, K. Sjogreen Gleisner, C Chiesa, M. Lassmann, Nicolas Chouin, et al.
(2018) European Journal of Nuclear Medicine and Molecular Imaging, 45 p.152-154
Artikel i tidskriftVariations in the practice of molecular radiotherapy and implementation of dosimetry : results from a European survey
Katarina Sjögreen Gleisner, Emiliano Spezi, Pavel Solny, Pablo Minguez Gabina, Francesco Cicone, et al.
(2017) EJNMMI Physics, 4
Artikel i tidskriftSPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Johan Gustafsson, Anna Sundlöv, Katarina Sjögreen Gleisner
(2017) EJNMMI Research, 7
Artikel i tidskriftDosimetry-based treatment planning for molecular radiotherapy : A summary of the 2017 report from the Internal Dosimetry Task Force
Caroline Stokke, Pablo Minguez Gabiña, Pavel Solný, Francesco Cicone, Mattias Sandström, et al.
(2017) EJNMMI Physics, 4
Artikel i tidskriftThe conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
C. Chiesa, K. Sjogreen Gleisner, G. Flux, J. Gear, S. Walrand, et al.
(2017) European Journal of Nuclear Medicine and Molecular Imaging, 44 p.1783-1786
Artikel i tidskriftComparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy : The Devil Is in the Details
Glenn D Flux, Frederik A Verburg, Carlo Chiesa, Manuel Bardiès, Katarina Sjögreen Gleisner, et al.
(2017) Journal of Nuclear Medicine, 58 p.862-862
Artikel i tidskriftIndividualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Anna Sundlöv, Katarina Sjögreen-Gleisner, Johanna Svensson, Michael Ljungberg, Tomas G Olsson, et al.
(2017) European Journal of Nuclear Medicine and Molecular Imaging, 44 p.1480-1489
Artikel i tidskriftPersonalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
Michael Ljungberg, Katarina Sjögreen Gleisner
(2016) Biomedicines, 4 p.1-21
Artikel i tidskriftWhole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer
PABLO MINGUEZ GABINA, Glenn Flux, José Genollá, Alejandro Delgado, Emilia Rodeño, et al.
(2016) Medical Physics, 43 p.5279-5287
Artikel i tidskriftMIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
Michael Ljungberg, Anna Celler, Mark W Konijnenberg, Keith F Eckerman, Yuni K Dewaraja, et al.
(2016) Journal of Nuclear Medicine, 57 p.151-162
Artikel i tidskriftBiologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with (131)I-mIBG.
Pablo Minguez Gabina, Johan Ruben Gustafsson, Glenn Flux, Katarina Sjögreen Gleisner
(2016) Physics in Medicine and Biology, 61 p.2532-2551
Artikel i tidskriftDosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
PABLO MINGUEZ GABINA, Glenn Flux, Jose Genolla, Sonia Guayambuco, Alejandro Delgado, et al.
(2015) Medical Physics, 42 p.3969-3978
Artikel i tidskriftHybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
Michael Ljungberg, Katarina Sjögreen Gleisner
(2015) Diagnostics, 5 p.296-317
Artikel i tidskriftUncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy.
Johan Ruben Gustafsson, Gustav Brolin, Maurice Cox, Michael Ljungberg, Lena Johansson, et al.
(2015) Physics in Medicine and Biology, 60 p.8329-8346
Artikel i tidskriftLong-term retention of 177Lu/177mLu-Dotatate in patients investigated by gamma spectrometry and gamma camera imaging.
Katarina Sjögreen Gleisner, Gustav Brolin, Anna Sundlöv, Edita Mjekiqi, Karl Östlund, et al.
(2015) Journal of Nuclear Medicine, 56 p.976-984
Artikel i tidskriftPharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in (177)Lu-DOTATATE peptide receptor radionuclide therapy.
Gustav Brolin, Johan Ruben Gustafsson, Michael Ljungberg, Katarina Sjögreen Gleisner
(2015) Physics in Medicine and Biology, 60 p.6131-6149
Artikel i tidskriftTestis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
Suaad Meerkhan, Katarina Sjögreen Gleisner, Erik Larsson, Sven-Erik Strand, Bo-Anders Jönsson
(2014) Physics in Medicine and Biology, 59 p.7889-7904
Artikel i tidskriftOn the biologically effective dose (BED)-using convolution for calculating the effects of repair: I. Analytical considerations.
Johan Ruben Gustafsson, Per Nilsson, Katarina Sjögreen Gleisner
(2013) Physics in Medicine and Biology, 58 p.1507-1527
Artikel i tidskriftDynamic (99m)Tc-MAG3 renography: images for quality control obtained by combining pharmacokinetic modelling, an anthropomorphic computer phantom and Monte Carlo simulated scintillation camera imaging.
Gustav Brolin, Katarina Sjögreen Gleisner, Michael Ljungberg
(2013) Physics in Medicine and Biology, 58 p.3145-3161
Artikel i tidskriftOn the biologically effective dose (BED)-using convolution for calculating the effects of repair: II. Numerical considerations.
Johan Ruben Gustafsson, Per Nilsson, Katarina Sjögreen Gleisner
(2013) Physics in Medicine and Biology, 58 p.1529-1548
Artikel i tidskriftPatient-Specific Whole-Body Attenuation Correction Maps from a CT System for Conjugate-View-Based Activity Quantification: Method Development and Evaluation.
Katarina Sjögreen Gleisner, Michael Ljungberg
(2012) Cancer Biotherapy & Radiopharmaceuticals, 27 p.652-664
Artikel i tidskriftThe accuracy of absorbed dose estimates in tumours determined by Quantitative SPECT: A Monte Carlo study.
Michael Ljungberg, Katarina Sjögreen Gleisner
(2011) Acta oncologica (Stockholm, Sweden), 50 p.981-989
Artikel i tidskriftDosimetry in patients with B-cell lymphoma treated with [90Y]ibritumomab tiuxetan or [131I]tositumomab.
Katarina Sjögreen Gleisner, Y K Dewaraja, C Chiesa, Jan Tennvall, Ola Lindén, et al.
(2011) Quarterly Journal of Nuclear Medicine and Molecular Imaging, 55 p.126-154
Artikel i tidskriftImage-based patient-specific dosimetry for radionuclide therapy
Michael Ljungberg, Katarina Sjögreen Gleisner
(2011) [Host publication title missing] , p.251-265
KonferensbidragLu-177-[DOTA0,Tyr3] Octreotate Therapy in Patients With Disseminated Neuroendocrine Tumors: Analysis of Dosimetry With Impact on Future Therapeutic Strategy
Michael Garkavij, Mattias Nickel, Katarina Sjögreen Gleisner, Michael Ljungberg, Tomas G Ohlsson, et al.
(2010) Cancer, 116 p.1084-1092
Artikel i tidskriftExtracorporeal techniques for improving radioimmunotherapy of disseminated malignant tumors
Rune Nilsson, Michael Garkavij, Ola Lindén, Katarina Sjögreen Gleisner, Michael Ljungberg, et al.
(2010) Targeted Radionuclide Therapy
Del av eller Kapitel i bok90Y Bremsstrahlung Imaging for Absorbed-Dose Assessment in High-Dose Radioimmunotherapy.
David Minarik, Katarina Sjögreen Gleisner, Ola Lindén, Karin Wingårdh, Jan Tennvall, et al.
(2010) Journal of Nuclear Medicine, 51 p.1974-1978
Artikel i tidskriftHigh-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Jacek Toporski, Michael Garkavij, Jan Tennvall, Ingrid Øra, Katarina Sjögreen Gleisner, et al.
(2009) Biology of Blood and Marrow Transplantation, 15 p.1077-1085
Artikel i tidskriftPeptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results
Michael Garkavij, Mattias Nickel, Katarina Sjögreen Gleisner, Michael Ljungberg, Sven-Erik Strand, et al.
(2009) Neuroendocrinology, 90 p.44-44
Konferensbidrag: abstractEvaluation of quantitative planar (90)Y bremsstrahlung whole-body imaging.
David Minarik, Michael Ljungberg, P Segars, Katarina Sjögreen Gleisner
(2009) Physics in Medicine and Biology, 54 p.5873-5883
Artikel i tidskriftRegistration of serial SPECT/CT images for three-dimensional dosimetry in radionuclide therapy.
Katarina Sjögreen Gleisner, David Rueckert, Michael Ljungberg
(2009) Physics in Medicine and Biology, 54 p.6181-6200
Artikel i tidskriftDevelopment and evaluation of a pharmacokinetic model for prediction of radioimmunotherapy based on pretherapy data.
Mattias Nickel, Sven-Erik Strand, Ola Lindén, Karin Wingårdh, Jan Tennvall, et al.
(2009) Cancer Biotherapy & Radiopharmaceuticals, 24 p.111-121
Artikel i tidskriftEvaluation of quantitative (90)Y SPECT based on experimental phantom studies.
David Minarik, Katarina Sjögreen Gleisner, Michael Ljungberg
(2008) Physics in Medicine and Biology, 53 p.5689-5703
Artikel i tidskriftConsequences of Inadvertent Radioiodine Treatment of Graves' Disease and Thyroid Cancer in Undiagnosed Pregnancy. Can We Rely on Routine Pregnancy Testing?
Gertrud E B Berg, Lars Jacobsson, Ernst H Nyström, Katarina Sjögreen Gleisner, Jan Tennvall
(2008) Acta Oncologica, 47 p.145-149
Artikel i tidskriftPeptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results
Michael Garkavij, Katarina Sjögreen Gleisner, Mattias Nickel, Tomas G Ohlsson, Karin Wingårdh, et al.
(2008) Cancer Biotherapy and Radiopharmaceuticals, 23 p.524-525
Konferensbidrag: abstractParametric images of antibody pharmacokinetics based on serial quantitative whole-body imaging and blood sampling
Katarina Sjögreen Gleisner, Mattias Nickel, Ola Lindén, Kjell Erlandsson, Karin Wingårdh, et al.
(2007) Journal of Nuclear Medicine, 48 p.1369-1378
Artikel i tidskriftA new method to obtain transmission images for planar whole-body activity quantification.
David Minarik, Katarina Sjögreen Gleisner, Michael Ljungberg
(2005) Cancer Biotherapy & Radiopharmaceuticals, 20 p.72-76
Artikel i tidskriftThe LundADose Method for Planar Image Activity Quantification and Absorbed-Dose Assessment in Radionuclide Therapy.
Katarina Sjögreen Gleisner, Michael Ljungberg, Karin Wingårdh, David Minarik, Sven-Erik Strand
(2005) Cancer Biotherapy & Radiopharmaceuticals, 20 p.92-97
Artikel i tidskrift3D absorbed dose calculations based on SPECT: Evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
Michael Ljungberg, E Frey, Katarina Sjögreen Gleisner, XW Liu, Y Dewaraja, et al.
(2003) Cancer Biotherapy & Radiopharmaceuticals, 18 p.99-107
Artikel i tidskriftA 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
Michael Ljungberg, Katarina Sjögreen Gleisner, Xiaowei Liu, Eric Frey, Yuni Dewaraja, et al.
(2002) Journal of Nuclear Medicine, 43 p.1101-1109
Artikel i tidskriftAn activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.
Katarina Sjögreen Gleisner, Michael Ljungberg, Sven-Erik Strand
(2002) Journal of Nuclear Medicine, 43 p.972-982
Artikel i tidskriftRegistration of emission and transmission whole-body scintillation-camera images
Katarina Sjögreen Gleisner, Michael Ljungberg, Karin Wingårdh, Kjell Erlandsson, Sven-Erik Strand
(2001) Journal of Nuclear Medicine, 42 p.1563-1570
Artikel i tidskriftImage Processing for Quantitative Scintillation-Camera Imaging. Application to Radionuclide Therapy.
Katarina Sjögreen Gleisner
(2001)
DoktorsavhandlingRadioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas
Ola Lindén, Jan Tennvall, Eva Cavallin-Ståhl, Lennart Darte, Michael Garkavij, et al.
(1999) Clinical Cancer Research, 5 p.3287-3291
Artikel i tidskriftDeformable Fourier surfaces for volume segmentation in SPECT
L Floreby, Katarina Sjögreen Gleisner, Leif Sörnmo, Michael Ljungberg
(1998) Proceeedings of the Fourteenth International Conference on Pattern Recognition, 1 p.358-360
KonferensbidragBoundary finding using Fourier surfaces of increasing order
L Floreby, Leif Sörnmo, Katarina Sjögreen Gleisner
(1998) Proceeedings of the Fourteenth International Conference on Pattern Recognition, 1 p.465-467
KonferensbidragRegistration of abdominal CT and SPECT images using Compton scatter data
Katarina Sjögreen Gleisner, Michael Ljungberg, Kjell Erlandsson, Lars Floreby, Sven-Erik Strand
(1997) Lecture Notes in Computer Science, 1230 p.232-244
Del av eller Kapitel i bokBiodistribution and pharmacokinetics of 125I/131I pair-labelled biotinylated chimeric BR96 in colon carcinoma isografted rats
Jianing Chen, Sven-Erik Strand, M Isaksson, Kaj Ljunggren, Katarina Sjögreen Gleisner, et al.
(1996) Tumor Targeting, 2 p.204-214
Artikel i tidskriftHigh resolution pinhole SPECT for tumor imaging
Sven-Erik Strand, Marijana Ivanovic, Kjell Erlandsson, David A Weber, Dinko Franceschi, et al.
(1993) Acta Oncologica, 32 p.861-867
Artikel i tidskrift